Evidence map›Paper›PMID 33773915›Full record

ArticleUrologic oncology2021

Diagnostic renal mass biopsy is associated with individual categories of PADUA and RENAL nephrometry scores: Analysis of diagnostic and concordance rates with surgical resection.

Ricardo B Fonseca, Melissa M Straub Hogan, Meghan E Kapp, Frances Cate, Alice Coogan, Sandeep Arora, Jennifer Gordetsky, Woodson W Smelser, Peter E Clark, Justin Cates and 1 more

Open access · greenAbstract read
In one paragraph

Article in Urologic oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Ricardo B FonsecaVanderbilt University Medical Center, Department of Radiology and Radiological Sciences; Nashville, TN.
Melissa M Straub HoganVanderbilt University Medical Center, Department of Pathology, Immunology, and Microbiology; Nashville, TN.
Meghan E KappVanderbilt University Medical Center, Department of Pathology, Immunology, and Microbiology; Nashville, TN.
Frances CatePathGroup Laboratories, Brentwood, TN.
Alice CooganVanderbilt University Medical Center, Department of Pathology, Immunology, and Microbiology; Nashville, TN.
Sandeep AroraVanderbilt University Medical Center, Department of Radiology and Radiological Sciences; Nashville, TN.
Jennifer GordetskyVanderbilt University Medical Center, Department of Pathology, Immunology, and Microbiology; Nashville, TN.
Woodson W SmelserDepartment of Urologic Surgery, Vanderbilt University Medical Center, Nashville, TN.
Peter E ClarkDepartment of Urology, Urologic Oncology Levine Cancer Institute Atrium Health, Charlotte, NC.
Justin CatesVanderbilt University Medical Center, Department of Pathology, Immunology, and Microbiology; Nashville, TN.
Giovanna A GiannicoVanderbilt University Medical Center, Department of Pathology, Immunology, and Microbiology; Nashville, TN. Electronic address: giovanna.giannico@vumc.org.
Nashville Oncology Associates · USVanderbilt University Medical Center · USLevine Cancer Institute · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863NCATS NIH HHS UL1 TR002243
6 · The paper itself

Abstract

backgroundRenal mass biopsy (RMB) is a safe and accurate method for diagnosis and clinical management of renal masses. However, the non-diagnostic rate is a limiting factor. We tested the hypothesis that imaging characteristics and anatomic complexity of the mass may impact RMB diagnostic outcome using the preoperative aspects and dimensions used for an anatomical (PADUA) classification and radius-exophytic/endophytic-nearness-anterior/posterior-location (RENAL) score. MATERIAL AND

methodsSingle institution, retrospective study of 490 renal masses from 443 patients collected from 2001 to 2018. Outcome measurements include (1) diagnostic and concordance rates amongst RMB types and RMB with surgical resection specimens; (2) association between diagnostic RMB and anatomical complexity of renal masses. The analysis was conducted in unselected masses and small renal masses (SRMs).

resultsRMB was performed by fine needle aspiration (FNA), core needle biopsy (CNB), or both (FNA+CNB). Non-diagnostic rate was significantly higher for FNA compared to CNB and FNA+CNB in both unselected and SRMs. Subset analysis in the FNA+CNB group showed similar diagnostic rates for FNA and CNB. In unselected masses, specificity for FNA, CNB, and FNA+CNB was 100%. Sensitivity was higher for CNB (90.1%, P = 0.002) and FNA+CNB (96.3%, P = 0.004) compared to FNA (66.7%). For unselected masses, endophytic growth predicted a non-diagnostic CNB. R.E.N.A.L location entirely between the polar lines (central) and entirely above the upper polar line predicted a diagnostic CNB. Sonography-guidance predicted a diagnostic FNA. For SRMs, non-diagnostic CNB was associated with endophytic growth, while diagnostic CNB was associated with renal sinus invasion and operator experience. More cystic masses were sampled by FNA, but diagnostic results were similar for FNA and CNB.

conclusionsEndophytic growth consistently predicted a non-diagnostic CNB in unselected and SRMs, whereas sonography-guidance predicted a diagnostic FNA. Cystic masses could be adequately sampled by FNA.

Indexed as

AgedBiopsy, Fine-NeedleBiopsy, Large-Core NeedleFemaleHumansKidneyKidney NeoplasmsMaleMiddle AgedRetrospective StudiesCore needle biopsyFine needle aspirationKidney neoplasmsRenal massRenal mass biopsy

Identifiers

PMID33773915
PMCPMC8205938
OpenAlexW3152079396

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.